Home » Topics » Science » New compound

New compound
RSS

Potent NK1 antagonist reported by Servier

Jan. 30, 1997

Dutch investigators find method of improving t-PA therapy

Jan. 30, 1997

Enantiospecific synthesis of SP antagonist from RPR

Jan. 28, 1997

Mediolanum prepares novel quinolone antibacterial agents

Jan. 28, 1997

Orally active anti-PCP agents developed by U.S. investigators

Jan. 28, 1997

Korean investigators isolate natural antioxidant

Jan. 28, 1997

Novartis selects analgesic agent as clinical candidate

Jan. 28, 1997

Spotlight on influenza sialidase inhibitors

Jan. 28, 1997

Merck Frosst discovers orally active COX-2 inhibitors

Jan. 24, 1997

Merck & Co. investigates thrombin inhibitors

Jan. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...